ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung - 
66185001 Roche Pharma (Schweiz) AG
Ocrevus, Konzentrat zur Herstellung einer Infusionslösung20.09.2017
  20.09.2017
(L04AG08) 
WHO-DDD 
01.99. 
01.99. 
A  
Yes 
IP 
5324.47Yes
    
10 %5770.70
  
7680661850010Biotechnologika
7230269 
Composition
ocrelizumabum 300 mg, natrii acetas trihydricus, acidum aceticum glaciale, trehalosum dihydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 10 ml corresp. natrium 3.6 mg.
Packungsbestandteile
Concentrate for infusion 
  
 
Active AgentDose
Ocrelizumabum300mg / 10ml
BAG: Active AgentDose
Ocrelizumabum300 mg
 
Inactive agents
Acidum Aceticum Glaciale
Sodium Acetate Trihydrate
Polysorbatum 20
Trehalosum Dihydricum
 
Source
Data was imported : 06.04.2022 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2025 ©ywesee GmbH
Settings | Help | FAQ | Login | Contact | Home